Vertex Pharmaceuticals Inc / Ma

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

593,947

Value ($000)

269,272

Weight

0.2%

2020 Q1 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	269,272	0.2%	593,947	12/31/2025
2025 Q3	11/13/2025	149,291	0.1%	381,195	9/30/2025
2025 Q2	8/13/2025	27,366	0.0%	61,470	6/30/2025
2024 Q4	2/12/2025	3,731	0.0%	9,265	12/31/2024
2022 Q4	2/14/2023	1,511	0.0%	5,233	12/31/2022
2022 Q3	11/14/2022	1,474	0.0%	5,092	9/30/2022
2022 Q2	8/15/2022	2,759	0.0%	9,790	6/30/2022
2021 Q4	2/14/2022	5,325	0.0%	24,249	12/31/2021
2021 Q2	8/13/2021	65,349	0.1%	324,105	6/30/2021
2021 Q1	5/14/2021	46,752	0.1%	217,561	3/31/2021
2020 Q4	2/12/2021	92,361	0.1%	390,799	12/31/2020
2020 Q3	11/12/2020	26,127	0.0%	96,013	9/30/2020
2020 Q2	8/12/2020	23,974	0.0%	82,582	6/30/2020
2020 Q1	5/15/2020	16,698	0.0%	70,176	3/31/2020